Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ruanmaijian decoction
- Development stage
- Preclinical
- Lead developer
- Longhua Hospital Shanghai University of Traditional Chinese Medicine
- Administration
- Oral
01
Overview
Ruanmaijian decoction (also known as Yishen Huazhuo decoction) is a Traditional Chinese Medicine (TCM) herbal formula developed by Longhua Hospital, affiliated with the Shanghai University of Traditional Chinese Medicine. It is primarily indicated for the treatment of atherosclerosis and carotid atherosclerosis, specifically in patients presenting with the 'kidney-deficiency' syndrome according to TCM diagnostics. The decoction is typically administered as an adjunct to standard Western medical treatments, such as statins, to enhance the stabilization and regression of atherosclerotic plaques. Its therapeutic approach, 'Yishen Huazhuo,' focuses on tonifying the kidney and clearing metabolic 'turbidity' (lipids and inflammation) to improve vascular function and reduce cardiovascular risk.
- Other names
- RuanmaijianYishen Huazhuo decoctionYishen Huazhuo formulaYishen Huazhuo Ruanmaijian decoction
02
Targets
MAPK3 (Mitogen-activated protein kinase 1)Ephrin type-A receptor 2/ephrin-A1 pathway
Beyond the preview
Go deeper on Ruanmaijian decoction.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ruanmaijian decoction.